Effects of blood pump orientation on performance: In vitro assessment of universal advanced ventricular assist device.


Journal

Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 04 11 2019
revised: 25 02 2020
accepted: 25 03 2020
pubmed: 3 4 2020
medline: 12 10 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

An advanced ventricular assist device (VAD), which is under development in our institution, has specific features that allow changes in the axial rotor position and pump performance by intrapump pressure difference. However, performance could be influenced by the pump orientation because of the effect of gravity on the rotor position. The purpose of this study was to evaluate the effects of pump orientation on the pump performance, including pulse pressure and regurgitant flow through the pump when the pump was stopped. Bench testing of the VAD was performed on a static or pulsatile mock loop with a pneumatic device to simulate the native ventricle. The pump performance, including pressure-flow curve, pulsatility, and regurgitant flow, was evaluated at several angles, ranging from -90° (inlet pointed upward) to +90° (inlet pointed downward) at pump speeds of 2000, 2500, 3000, and 3500 rpm. The pump performance was slightly lower at +90° at all rotational speeds, compared with -90°. The pulse pressure on the pulsatile mock loop (80 bpm) was 50 mm Hg without pump support, remained at 50 mm Hg during pump support, and was not changed by orientation (-90°, 0°, and +90°). When the pump was stopped, the regurgitant flow was near 0 L/min at all angles. Pump orientation had a minor effect on pump performance, with no effect on pulse pressure or regurgitant flow when the pump was stopped. This indicates that the effect of gravity on the rotor assembly is insignificant.

Identifiants

pubmed: 32239763
doi: 10.1111/aor.13690
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1060

Subventions

Organisme : NHLBI NIH HHS
ID : R21 HL133871
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5R21HL133871
Pays : United States

Informations de copyright

© 2020 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.

Références

Moazami N, Steffen RJ, Naka Y, Jorde U, Bailey S, Murali S, et al. Lessons learned from the first fully magnetically levitated centrifugal lvad trial in the united states: the duraheart trial. Ann Thorac Surg. 2014;98:541-7.
Fukamachi K, Horvath DJ, Byram N, Sunagawa G, Karimov JH, Moazami N. Advanced ventricular assist device with pulse augmentation and automatic regurgitant-flow shut-off. J Heart Lung Transplant. 2016;35:1519-21.
Asama J, Shinshi T, Hoshi H, Takatani S, Shimokohbe A. Dynamic characteristics of a magnetically levitated impeller in a centrifugal blood pump. Artif Organs. 2007;31:301-11.
Paul G, Rezaienia MA, Rahideh A, Munjiza A, Korakianitis T. The effects of ambulatory accelerations on the stability of a magnetically suspended impeller for an implantable blood pump. Artif Organs. 2016;40:867-76.
Kosaka R, Maruyama O, Nishida M, Yada T, Saito S, Hirai S, et al. Improvement of hemocompatibility in centrifugal blood pump with hydrodynamic bearings and semi-open impeller: In vitro evaluation. Artif Organs. 2009;33:798-804.
Horvath DJ, Karimov JH, Byram NA, Kuban BD, Sunagawa G, Moazami N, et al. Advantages of integrating pressure-regulating devices into mechanical circulatory support pumps. ASAIO J. 2019;65:e1-3.
Miyamoto T, Byram N, Karimov JH, Adams J, Dessoffy R, Kuban BD, et al. The design modification of advanced ventricular assist device to enhance pulse augmentation and regurgitant flow shut-off. Artif Organs 2019;43(10):961-5.

Auteurs

Takuma Miyamoto (T)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Yuichiro Kado (Y)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Anthony R Polakowski (AR)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

David J Horvath (DJ)

R1 Engineering, Euclid, OH, USA.

Barry D Kuban (BD)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Medical Device Solutions, Cleveland Clinic, Cleveland, OH, USA.

Kiyotaka Fukamachi (K)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Jamshid H Karimov (JH)

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH